Chelation Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Thalassemia is a group of inherited blood disorders characterized by abnormal hemoglobin production, leading to anemia and other complications .

Chelation therapy to remove potentially toxic levels of lead was not associated with a reduction in CV events in post-MI patients with diabetes in the TACT2 trial.

Stem cell therapy is gaining traction for the treatment of thalassemia, especially for severe cases. Gene-edited cell therapy is also gaining popularity for the treatment of transfusion-dependent beta-thalassemia (TDT) in patients 12 years and older.Wilmington, Delaware, United States, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global thalassemia treatment market is slated to be valued at US$ 1.5 billion in 2031, with an expected value CAGR of 7.3%. Thalassemia is

According to Thailand's Ministry of Public Health, approximately 18-24 million or 30-40 percent of the Thai population carries the thalassemia gene, with moderately severe thalassemia patients requiring regular treatment, including blood transfusion and chelation therapy to remove excess iron from the blood.

Georgia doctor Charles Adams and his medical practice have been ordered to pay over $27.5 million for submitting false claims to Medicare for chelation therapy